Temporal Trends of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea

Coronary Artery Disease Clinical Trial

— COPE registry  

Official title:

Temporal Trends in the Incidence, Treatment Patterns, and Outcomes of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04834843
• Other study ID #: 2020AN0279
• Status: Completed
• Start date: January 1, 2009
• Est. completion date: December 31, 2020

Study information

• Verified date: April 2021
• Source: Wonju Severance Christian Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Cardiovascular disease (CVD) is caused by atherosclerosis of the artery and is classified into coronary artery disease, cerebrovascular disease, and peripheral arterial disease, depending on the location of the artery and the target organs. However, since CVD share a similar pathophysiology and the probability of incidence of other CVD in CVD patients is very high. It is thought that CVD incidence and mortality can be reduced by predicting the degree of incidence of other CVD in CVD patients. The aim of this study is to investigate the incidence and mortality of other CVD diseases in CVD patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 700000
• Est. completion date: December 31, 2020
• Est. primary completion date: December 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Koreans who diagnosed with coronary artery disease between 2009 and 2018
• Koreans who diagnosed with peripheral artery disease between 2009 and 2018
• Koreans who diagnosed with cerebrovascular disease between 2009 and 2018
• more than 18 years old

Exclusion Criteria:

• less than 18 years old

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia
• Peripheral Arterial Disease
• Peripheral Artery Disease

Intervention

Other:
• Observational study, no intervention
Observational study, no intervention

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Wonju Severance Christian Hospital

References & Publications (4)

Ahn S, Park YJ, Min SI, Kim SY, Ha J, Kim SJ, Kim HS, Yoon BW, Min SK. High prevalence of peripheral arterial disease in Korean patients with coronary or cerebrovascular disease. J Korean Med Sci. 2012 Jun;27(6):625-9. doi: 10.3346/jkms.2012.27.6.625. Epu — View Citation

Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombos — View Citation

Søgaard M, Nielsen PB, Skjøth F, Eldrup N, Larsen TB. Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study. Circulation. 2021 Mar 2;143(9):907-92 — View Citation

Sundaram V, Bloom C, Zakeri R, Halcox J, Cohen A, Bowrin K, Briere JB, Banerjee A, Simon DI, Cleland JGF, Rajagopalan S, Quint JK. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of coronary artery disease, cerebrovascular disease, peripheral arterial disease	Among all Koreans, percentage (%) of patients with a history of being diagnosed with CVD and underwent in-hospital treatment	Up to 10 years
Secondary	1-year mortality	The percentage (%) of any CVD related mortality	Up to 1 year